Credit Suisse’s Arcadia Biosciences RKDA Stock Holding History

Credit Suisse’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-24	Closed	-$49K	–	4229
2016 Q2	$49K	Buy	+24	New	+$40.2K	﹤0.01%	4151
2015 Q4	–	Sell	-20	Closed	-$48K	–	4336
2015 Q3	$48K	Sell	20 -1	-5%	-$4.16K	﹤0.01%	4179
2015 Q2	$108K	Buy	+21	New	+$131K	﹤0.01%	4370

Other funds holding RKDA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Credit Suisse's RKDA Position: Q3 2016 in Review

Credit Suisse sold out of Arcadia Biosciences (RKDA) in Q3 2016, closing a stake of 24 shares — an estimated $49K sold.

Credit Suisse first reported a position in RKDA in Q2 2015 and held it in 3 quarters. The position peaked at $108K in Q2 2015. 16 funds tracked by Wall St. Rank hold RKDA as of Q3 2016.

Credit Suisse reported no remaining Arcadia Biosciences position as of Q3 2016 after selling out during the quarter.
Credit Suisse sold 24 Arcadia Biosciences shares in Q3 2016, an estimated $49K.
Credit Suisse first reported a position in Arcadia Biosciences in Q2 2015 and held it in 3 quarters.
Credit Suisse's Arcadia Biosciences position peaked at $108K in Q2 2015.
16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2016.

Based on Credit Suisse's 13F filing for Q3 2016, filed 15 Nov 2016.